These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7127337)

  • 1. Etoposide for therapy-resistant testicular tumors.
    Varini M; Cavalli F
    Cancer Treat Rev; 1982 Jun; 9 Suppl():73-8. PubMed ID: 7127337
    [No Abstract]   [Full Text] [Related]  

  • 2. Etoposide salvage therapy for refractory germ cell tumors: an update.
    Williams SD; Einhorn LH
    Cancer Treat Rev; 1982 Jun; 9 Suppl():67-71. PubMed ID: 6290056
    [No Abstract]   [Full Text] [Related]  

  • 3. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
    Bremer K; Niederle N; Krischke W; Higi M; Scheulen ME; Schmidt CG; Seeber S
    Cancer Treat Rev; 1982 Jun; 9 Suppl():79-84. PubMed ID: 7127338
    [No Abstract]   [Full Text] [Related]  

  • 4. VP-16-213 (etoposide) in the management of germinal testis tumors.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():391-400. PubMed ID: 2421333
    [No Abstract]   [Full Text] [Related]  

  • 5. VP16-213 as a single agent in advanced testicular tumors.
    Fitzharris BM; Kaye SB; Saverymuttu S; Newlands ES; Barrett A; Peckham MJ; McElwain TJ
    Eur J Cancer (1965); 1980 Sep; 16(9):1193-7. PubMed ID: 7227446
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase II study of oral VP-16-213 in non-seminomatous testicular cancer.
    Cavalli F; Klepp O; Renard J; Röhrt M; Alberto P
    Eur J Cancer (1965); 1981 Feb; 17(2):245-9. PubMed ID: 7262161
    [No Abstract]   [Full Text] [Related]  

  • 7. VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms.
    Mortimer J; Bukowski RM; Montie J; Hewlett JS; Livingston RB
    Cancer Chemother Pharmacol; 1982; 7(2-3):215-8. PubMed ID: 6282486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide (VP-16-213). Current status of an active anticancer drug.
    O'Dwyer PJ; Leyland-Jones B; Alonso MT; Marsoni S; Wittes RE
    N Engl J Med; 1985 Mar; 312(11):692-700. PubMed ID: 2983208
    [No Abstract]   [Full Text] [Related]  

  • 9. Etoposide (VP 16-213; VePesid).
    Med Lett Drugs Ther; 1984 May; 26(661):48-9. PubMed ID: 6325855
    [No Abstract]   [Full Text] [Related]  

  • 10. Etoposide: a new anti-cancer agent.
    Arnold AM; Whitehouse JM
    Lancet; 1981 Oct; 2(8252):912-5. PubMed ID: 6117692
    [No Abstract]   [Full Text] [Related]  

  • 11. Does etoposide have curative potential?
    Ignoffo RJ
    Clin Pharm; 1983; 2(2):167. PubMed ID: 6309470
    [No Abstract]   [Full Text] [Related]  

  • 12. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
    Goldhirsch A; Joss R; Cavalli F; Brunner KW
    Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
    [No Abstract]   [Full Text] [Related]  

  • 13. Etoposide in the treatment of refractory breast cancer.
    Höffken K
    Cancer Treat Rev; 1982 Jun; 9 Suppl():63-6. PubMed ID: 7127336
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complete remission obtained in advanced testicular cancer treated by etoposide (NK-171)].
    Babaya K; Tsumatani K; Natsume O; Yoshie T; Kubota K; Ozono S; Hirao Y; Okajima E
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):604-7. PubMed ID: 2420282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
    Eagan RT
    Cancer Treat Rev; 1982 Jun; 9 Suppl():119-31. PubMed ID: 6889917
    [No Abstract]   [Full Text] [Related]  

  • 16. [Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
    Goldhirsch A; Joss R; Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1105-9. PubMed ID: 6266800
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VP-16 salvage therapy of PVB regimen-resistant testicular germ cell tumors].
    Yamazaki H; Yuichiro A; Kondo N; Imanaka K; Machida T
    Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1227-31. PubMed ID: 2446041
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
    Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
    Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of vepeside in mono- and polychemotherapy of various malignant neoplasms].
    Pawlicki M
    Nowotwory; 1983; 33(4):361-6. PubMed ID: 6369257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.